查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
糖尿病設備的全球市場 (2022年～2031年):產品類型別產業分析·規模·佔有率·成長·趨勢·預測
市場調查報告書
商品編碼
1166014

糖尿病設備的全球市場 (2022年～2031年):產品類型別產業分析·規模·佔有率·成長·趨勢·預測

Diabetes Devices Market (Product Type: Glucose Monitoring Devices, Insulin Delivery Devices, Diabetes Management Software, and Artificial Pancreas System) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 211 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球糖尿病設備的市場調查，彙整市場概要，市場成長的各種影響因素分析，技術趨勢，市場規模的轉變·預測，各種區分·各地區/主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 序文

第2章 前提與調查手法

第3章 摘要整理:全球糖尿病設備市場

第4章 市場概要

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球糖尿病設備市場分析·預測
  • 波特的五力分析

第5章 主要洞察

  • 技術的進步
  • 價值鏈分析
  • 世界及地區的估計糖尿病患者數
  • 糖尿病管理上新技術
  • COVID-19:影響分析

第6章 全球糖尿病設備市場分析·預測:各產品類型

  • 簡介·定義
  • 主要調查結果/展開
  • 市場規模·預測
    • 葡萄糖監測設備
    • 胰島素通知設備
    • 糖尿病管理軟體
    • 人工胰臟系統
  • 市場魅力

第7章 全球糖尿病設備市場分析·預測:各流通管道

  • 簡介·定義
  • 主要調查結果/展開
  • 市場規模·預測
    • 醫院藥局
    • 零售藥局
    • 線上藥局
    • 糖尿病診所/中心
  • 市場魅力

第8章 全球糖尿病設備市場分析·預測:各地區

  • 主要調查結果
  • 市場規模·預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力

第9章 北美的糖尿病設備市場分析·預測

第10章 歐洲的糖尿病設備市場分析·預測

第11章 亞太地區的糖尿病設備市場分析·預測

第12章 南美的糖尿病設備市場分析·預測

第13章 中東·非洲的糖尿病設備市場分析·預測

第14章 競爭情形

  • 參與企業·競爭矩陣
  • 市場佔有率分析·各企業
  • 企業簡介
    • Medtronic
    • Novo Nordisk A/S
    • Sanofi
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • Becton Dickinson and Company
    • Tandem Diabetes Care, Inc.
    • Abbott Laboratories
    • Cellnovo
    • Insulet Corporation
    • LifeScan, Inc.
    • Owen Mumford Ltd.
Product Code: TMRGL14

TMR's report on global diabetes devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global diabetes devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global diabetes devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the diabetes devices market.

The report delves into the competitive landscape of the global diabetes devices market. Key players operating in the global diabetes devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global diabetes devices market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Diabetes Devices Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Diabetes Devices Market Analysis and Forecast, 2017-2031
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Value Chain Analysis
  • 5.3. Estimated Number of People with Diabetes Worldwide and Per Region (Age 20-79 years)
  • 5.4. Emerging Technologies in Diabetes Management
  • 5.5. COVID-19 Impact Analysis

6. Global Diabetes Devices Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Glucose Monitoring Devices
      • 6.3.1.1. Self-monitoring Blood Glucose Meters
      • 6.3.1.2. Blood Glucose Testing Strips
      • 6.3.1.3. Lancets
      • 6.3.1.4. Continuous Glucose Monitoring Meters
    • 6.3.2. Insulin Delivery Devices
      • 6.3.2.1. Insulin Syringes
      • 6.3.2.2. Insulin Pens
      • 6.3.2.3. Insulin Pumps
    • 6.3.3. Diabetes Management Software
    • 6.3.4. Artificial Pancreas System
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Diabetes Devices Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Pharmacies
    • 7.3.4. Diabetes Clinics/Centers
  • 7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Diabetes Devices Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Diabetes Devices Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product Type, 2017-2031
    • 9.2.1. Glucose Monitoring Devices
      • 9.2.1.1. Self-monitoring Blood Glucose Meters
      • 9.2.1.2. Blood Glucose Testing Strips
      • 9.2.1.3. Lancets
      • 9.2.1.4. Continuous Glucose Monitoring Meters
    • 9.2.2. Insulin Delivery Devices
      • 9.2.2.1. Insulin Syringes
      • 9.2.2.2. Insulin Pens
      • 9.2.2.3. Insulin Pumps
    • 9.2.3. Diabetes Management Software
    • 9.2.4. Artificial Pancreas System
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
    • 9.3.4. Diabetes Clinics/Centers
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product Type
    • 9.5.2. By Distribution Channel
    • 9.5.3. By Country

10. Europe Diabetes Devices Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Glucose Monitoring Devices
      • 10.2.1.1. Self-monitoring Blood Glucose Meters
      • 10.2.1.2. Blood Glucose Testing Strips
      • 10.2.1.3. Lancets
      • 10.2.1.4. Continuous Glucose Monitoring Meters
    • 10.2.2. Insulin Delivery Devices
      • 10.2.2.1. Insulin Syringes
      • 10.2.2.2. Insulin Pens
      • 10.2.2.3. Insulin Pumps
    • 10.2.3. Diabetes Management Software
    • 10.2.4. Artificial Pancreas System
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
    • 10.3.4. Diabetes Clinics/Centers
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product Type
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Diabetes Devices Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Glucose Monitoring Devices
      • 11.2.1.1. Self-monitoring Blood Glucose Meters
      • 11.2.1.2. Blood Glucose Testing Strips
      • 11.2.1.3. Lancets
      • 11.2.1.4. Continuous Glucose Monitoring Meters
    • 11.2.2. Insulin Delivery Devices
      • 11.2.2.1. Insulin Syringes
      • 11.2.2.2. Insulin Pens
      • 11.2.2.3. Insulin Pumps
    • 11.2.3. Diabetes Management Software
    • 11.2.4. Artificial Pancreas System
  • 11.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Retail Pharmacies
    • 11.3.3. Online Pharmacies
    • 11.3.4. Diabetes Clinics/Centers
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product Type
    • 11.5.2. By Distribution Channel
    • 11.5.3. By Country/Sub-region

12. Latin America Diabetes Devices Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Glucose Monitoring Devices
      • 12.2.1.1. Self-monitoring Blood Glucose Meters
      • 12.2.1.2. Blood Glucose Testing Strips
      • 12.2.1.3. Lancets
      • 12.2.1.4. Continuous Glucose Monitoring Meters
    • 12.2.2. Insulin Delivery Devices
      • 12.2.2.1. Insulin Syringes
      • 12.2.2.2. Insulin Pens
      • 12.2.2.3. Insulin Pumps
    • 12.2.3. Diabetes Management Software
    • 12.2.4. Artificial Pancreas System
  • 12.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Pharmacies
    • 12.3.4. Diabetes Clinics/Centers
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product Type
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Diabetes Devices Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Glucose Monitoring Devices
      • 13.2.1.1. Self-monitoring Blood Glucose Meters
      • 13.2.1.2. Blood Glucose Testing Strips
      • 13.2.1.3. Lancets
      • 13.2.1.4. Continuous Glucose Monitoring Meters
    • 13.2.2. Insulin Delivery Devices
      • 13.2.2.1. Insulin Syringes
      • 13.2.2.2. Insulin Pens
      • 13.2.2.3. Insulin Pumps
    • 13.2.3. Diabetes Management Software
    • 13.2.4. Artificial Pancreas System
  • 13.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.3.1. Hospital Pharmacies
    • 13.3.2. Retail Pharmacies
    • 13.3.3. Online Pharmacies
    • 13.3.4. Diabetes Clinics/Centers
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product Type
    • 13.5.2. By Distribution Channel
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2021
  • 14.3. Company Profiles
    • 14.3.1. Medtronic
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Strategic Overview
    • 14.3.2. Novo Nordisk A/S
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Strategic Overview
    • 14.3.3. Sanofi
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Strategic Overview
    • 14.3.4. Eli Lilly and Company
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Strategic Overview
    • 14.3.5. F. Hoffmann-La Roche Ltd.
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Strategic Overview
    • 14.3.6. Becton Dickinson and Company
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Strategic Overview
    • 14.3.7. Tandem Diabetes Care, Inc.
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Strategic Overview
    • 14.3.8. Abbott Laboratories
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Strategic Overview
    • 14.3.9. Cellnovo
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Strategic Overview
    • 14.3.10. Insulet Corporation
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. SWOT Analysis
      • 14.3.10.4. Strategic Overview
    • 14.3.11. LifeScan, Inc.
      • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.11.2. Product Portfolio
      • 14.3.11.3. SWOT Analysis
      • 14.3.11.4. Strategic Overview
    • 14.3.12. Owen Mumford Ltd.
      • 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.12.2. Product Portfolio
      • 14.3.12.3. SWOT Analysis
      • 14.3.12.4. Strategic Overview

List of Tables

  • Table 01: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product type, 2017-2031
  • Table 02: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type - Glucose Monitoring Devices 2017-2031
  • Table 03: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type - Insulin Delivery Devices, 2017-2031
  • Table 04: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 05: Global Insulin Delivery Devices Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 08: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type - Glucose Monitoring Devices 2017-2031
  • Table 09: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type - Insulin Delivery Devices, 2017-2031
  • Table 10: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 11: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 13: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type - Glucose Monitoring Devices, 2017-2031
  • Table 14: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type - Insulin Delivery Devices, 2017-2031
  • Table 15: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 16: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 18: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017-2031
  • Table 19: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017-2031
  • Table 20: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017-2031
  • Table 24: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017-2031
  • Table 25: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 26: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 28: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017-2031
  • Table 29: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017-2031
  • Table 30: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Diabetes Devices Market, by Product, Market Size (US$ Mn), 2021 (A)
  • Figure 02: Global Diabetes Devices Market, by Distribution Channel, Market Share, 2021 (A)
  • Figure 03: Global Diabetes Devices Market Size (US$ Mn) Forecast, 2017-2031
  • Figure 04: Company Revenue Share (1)
  • Figure 05: Company Revenue Share (2)
  • Figure 06: Estimated Number of People with Diabetes Worldwide and Per Region (Age 20-79 years)
  • Figure 07: Global Diabetes Devices Market Value Share, by Product Type, 2021 and 2025
  • Figure 08: Global Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 09: Global Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
  • Figure 10: Global America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2021 and 2031
  • Figure 11: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Glucose Monitoring Devices, 2017-2031
  • Figure 12: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Insulin Delivery Devices, 2017-2031
  • Figure 13: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Monitoring Software, 2017-2031
  • Figure 14: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Artificial Pancreas System, 2017-2031
  • Figure 15: Global Diabetes Devices Market Value Share, by Distribution Channel, 2021 and 2025

Figure16: Global Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022-2031

  • Figure 17: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017-2031
  • Figure 18: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017-2031
  • Figure 19: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017-2031
  • Figure 20: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Clinics/ Centers, 2017-2031
  • Figure 21: Global Diabetes Device Market Scenario, by Country (1/1)
  • Figure 22: Global Diabetes Devices Market Value Share Analysis, by Region, 2021 and 2025
  • Figure 23: Global Diabetes Devices Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 24: North America Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 25: North America Diabetes Devices Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 26: North America Diabetes Devices Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 27: North America Diabetes Devices Market Value Share, by Product Type, 2021 and 2031
  • Figure 28: North America Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 29: North America Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
  • Figure 30: North America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2021 and 2031
  • Figure 31: North America Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Fig 32: North America Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022-2031

  • Figure 33: Europe Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 34: Europe Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 35: Europe Diabetes Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 36: Europe Diabetes Devices Market Value Share, by Product Type, 2021 and 2031
  • Figure 37: Europe Diabetes Devices Market Attractiveness Analysis, by Product Type, 2017-2031
  • Figure 38: Europe Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
  • Figure 39: Europe Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017-2031
  • Figure 40: Europe Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 41: Europe Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 42: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Forecast, by region, 2017-2031
  • Figure 43: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 44: Asia Pacific Diabetes Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 45: Asia Pacific Diabetes Devices Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 46: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 47: Asia Pacific Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
  • Figure 48: Asia Pacific Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017-2031
  • Figure 48: Asia Pacific Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017-2031
  • Figure 49: Asia Pacific Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 50: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 51: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Forecast, by region, 2017-2031
  • Figure 52: Latin America Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 53: Latin America Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 54: Latin America Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 55: Latin America Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 56: Latin America Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
  • Figure 57: Latin America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017-2031
  • Figure 58: Latin America Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 59: Latin America Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 60: Middle East & Africa Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast 2017-2031
  • Figure 61: Middle East & Africa Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 62: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 63: Middle East & Africa Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 64: Middle Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 65: Middle East & Africa Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031
  • Figure 66: Middle East & Africa Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017-2031
  • Figure 67: Middle East & Africa Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 68: Middle East & Africa Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 69: Medtronic, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017-2021
  • Figure 70: Medtronic, R&D Intensity and Sales & Marketing Intensity (%) - Company Level or Segment Level, 2017-2021
  • Figure 71: Medtronic, Breakdown of Net Sales, by Region 2017
  • Figure 72: Medtronic, Breakdown of Net Sales, by Business Segments, 2017
  • Figure 73: Novo Nordisk A/S, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017-2021
  • Figure 74: Novo Nordisk A/S, R&D Intensity and Sales & Marketing Intensity (%), 2017-2021
  • Figure 75: Novo Nordisk A/S, Breakdown of Net Sales, by Region 2021
  • Figure 76: Novo Nordisk A/S, Breakdown of Net Sales, by Business Segments, 2021
  • Figure 77: Sanofi, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017-2021
  • Figure 78: Sanofi, R&D Intensity and Sales & Marketing Intensity (US$ Bn), 2017-2021
  • Figure 79: Sanofi, Breakdown of Net Sales, by Region 2021
  • Figure 80: Sanofi, Breakdown of Net Sales, by Business Segments, 2021
  • Figure 81: Eli Lilly and Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017-2021
  • Figure 82: Eli Lilly and Company, R&D Intensity and Sales & Marketing Intensity - Company Level, 2017-2021
  • Figure 83: Eli Lilly and Company, Breakdown of Net Sales, by Region 2017
  • Figure 84: Eli Lilly and Company, Breakdown of Net Sales, by Endocrinology Segment, 2021
  • Figure 85: F. Hoffmann-La Roche Ltd., Revenue (US$ Bn) & Y-o-Y Growth (%), 2017-2021
  • Figure 86: F. Hoffmann-La Roche Ltd., R&D Intensity (US$ Bn), 2017-2021
  • Figure 87: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales of Diabetes Care Business Area, by Region 2021
  • Figure 88: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales, by Diagnostic Division, 2021
  • Figure 89: Becton, Dickinson and Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017-2021
  • Figure 90: Becton, Dickinson and Company, R&D Expense (US$ Mn), 2017-2021
  • Figure 91: Becton, Dickinson and Company, Breakdown of Net Sales, by Region 2021
  • Figure 92: Becton, Dickinson and Company, Breakdown of Net Sales, by BD Medical Business segment, 2021
  • Figure 93: Tandem Diabetes Care, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2017-2021
  • Figure 94: Tandem Diabetes Care, Inc., R&D Expense (US$ Mn), 2017-2021
  • Figure 95: Abbott Laboratories, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017-2021
  • Figure 96: Abbott Laboratories, R&D Intensity and Sales & Marketing Intensity - Company Level, 2017-2021
  • Figure 97: Abbott Laboratories, Breakdown of Net Sales, by Region 2021
  • Figure 98: Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2021
  • Figure 99: Cellnovo, Revenue (US$ Mn) & Y-o-Y Growth (%), 2017-2021
  • Figure 100: Insulet Corporation, Revenue (US$ Mn) & Y-o-Y Growth (%), 2017-2021
  • Figure 101: Insulet Corporation, R&D Intensity and Sales & Marketing Intensity (US$ Mn) - Company Level, 2017-2021
  • Figure 102: Insulet Corporation, Breakdown of Net Sales, by Region, 2021
  • Figure 103: Insulet Corporation, Breakdown of Net Sales, by Business Segments 2021
  • Figure 104: LifeScan, Inc., Concerned Company Revenue (US$ Bn) & Y-o-Y Growth (%), 2017-2021
  • Figure 105: LifeScan, Inc., R&D Intensity and Sales & Marketing Intensity - Company Level, 2017-2021
  • Figure 106: LifeScan, Inc., Breakdown of Net Sales, by Region (Company Level), 2021
  • Figure 107: LifeScan, Inc., Breakdown of Net Sales, (By Business And Business Segment Level), 2021